These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27209345)

  • 1. The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study.
    Fischer D; Hafner P; Rubino D; Schmid M; Neuhaus C; Jung H; Bieri O; Haas T; Gloor M; Fischmann A; Bonati U
    Neuromuscul Disord; 2016 Jul; 26(7):414-22. PubMed ID: 27209345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy.
    van de Velde NM; Hooijmans MT; Sardjoe Mishre ASD; Keene KR; Koeks Z; Veeger TTJ; Alleman I; van Zwet EW; Beenakker JM; Verschuuren JJGM; Kan HE; Niks EH
    Neurology; 2021 Aug; 97(5):e513-e522. PubMed ID: 34162720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measures.
    De Wel B; Iterbeke L; Huysmans L; Peeters R; Goosens V; Dubuisson N; van den Bergh P; Van Parijs V; Remiche G; De Waele L; Maes F; Dupont P; Claeys KG
    Eur J Neurol; 2024 Jul; 31(7):e16282. PubMed ID: 38504654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Speed T
    Xu T; Xu K; Song Y; Zhou Z; Fu H; Xu R; Cai X; Guo Y; Ye P; Xu H
    J Magn Reson Imaging; 2023 Oct; 58(4):1270-1278. PubMed ID: 36773028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
    Bonati U; Hafner P; Schädelin S; Schmid M; Naduvilekoot Devasia A; Schroeder J; Zuesli S; Pohlman U; Neuhaus C; Klein A; Sinnreich M; Haas T; Gloor M; Bieri O; Fischmann A; Fischer D
    Neuromuscul Disord; 2015 Sep; 25(9):679-85. PubMed ID: 26096788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal 2-point dixon muscle magnetic resonance imaging in becker muscular dystrophy.
    Bonati U; Schmid M; Hafner P; Haas T; Bieri O; Gloor M; Fischmann A; Fischer D
    Muscle Nerve; 2015 Jun; 51(6):918-21. PubMed ID: 25736228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.
    Gaeta M; Messina S; Mileto A; Vita GL; Ascenti G; Vinci S; Bottari A; Vita G; Settineri N; Bruschetta D; Racchiusa S; Minutoli F
    Skeletal Radiol; 2012 Aug; 41(8):955-61. PubMed ID: 22069033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.
    Sherlock SP; Zhang Y; Binks M; Marraffino S
    Biomark Med; 2021 Jun; 15(10):761-773. PubMed ID: 34155911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in Duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function.
    Song Y; Xu HY; Xu K; Guo YK; Xie LJ; Peng F; Xu R; Fu H; Yuan WF; Zhou ZQ; Cheng BC; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Jul; 53(8):1648-1658. PubMed ID: 36892624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of patients with Becker muscular dystrophy by histology, magnetic resonance imaging, function, and strength assessments.
    Comi GP; Niks EH; Cinnante CM; Kan HE; Vandenborne K; Willcocks RJ; Velardo D; Ripolone M; van Benthem JJ; van de Velde NM; Nava S; Ambrosoli L; Cazzaniga S; Bettica PU
    Muscle Nerve; 2022 Mar; 65(3):326-333. PubMed ID: 34918368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI.
    Abdulhady H; Sakr HM; Elsayed NS; El-Sobky TA; Fahmy N; Saadawy AM; Elsedfy H
    Acta Myol; 2022 Mar; 41(1):1-14. PubMed ID: 35465338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies.
    Bello L; Campadello P; Barp A; Fanin M; Semplicini C; Sorarù G; Caumo L; Calore C; Angelini C; Pegoraro E
    Sci Rep; 2016 Sep; 6():32439. PubMed ID: 27582364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnetic resonance imaging of dystrophinopathy that mimics adductor enthesopathy].
    Zheng YM; Li WZ; Wang ZX; Zhang W; Lv H; Xiao JX; Yuan Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):846-849. PubMed ID: 27752168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients.
    Wokke BH; Van Den Bergen JC; Hooijmans MT; Verschuuren JJ; Niks EH; Kan HE
    Muscle Nerve; 2016 Jan; 53(1):38-43. PubMed ID: 25847364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients.
    Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L
    J Neurol; 2023 Mar; 270(3):1439-1451. PubMed ID: 36385201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.
    Forbes SC; Arora H; Willcocks RJ; Triplett WT; Rooney WD; Barnard AM; Alabasi U; Wang DJ; Lott DJ; Senesac CR; Harrington AT; Finanger EL; Tennekoon GI; Brandsema J; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Radiology; 2020 Jun; 295(3):616-625. PubMed ID: 32286193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments.
    Kim HK; Laor T; Horn PS; Racadio JM; Wong B; Dardzinski BJ
    Radiology; 2010 Jun; 255(3):899-908. PubMed ID: 20501727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes in magnetic resonance imaging biomarkers of the gluteal muscle groups and functional ability in Duchenne muscular dystrophy: a 12-month cohort study.
    Song Y; Xu K; Xu HY; Guo YK; Xu R; Fu H; Yuan WF; Zhou ZQ; Xu T; Chen XJ; Wang YL; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Dec; 53(13):2672-2682. PubMed ID: 37889296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.